Biophytis Valuation
| BPTSDelisted Stock | USD 7.03 0.00 0.00% |
At this time, the firm appears to be overvalued. Biophytis shows a prevailing Real Value of $6.68 per share. The current price of the firm is $7.03. Our model approximates the value of Biophytis from analyzing the firm fundamentals such as Shares Owned By Institutions of 0.04 %, current valuation of 9.73 B, and Return On Equity of -12.44 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biophytis' price fluctuation is very steady at this time. Calculation of the real value of Biophytis is based on 3 months time horizon. Increasing Biophytis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biophytis stock is determined by what a typical buyer is willing to pay for full or partial control of Biophytis. Since Biophytis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biophytis Stock. However, Biophytis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.03 | Real 6.68 | Hype 7.03 |
The intrinsic value of Biophytis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biophytis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biophytis helps investors to forecast how Biophytis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biophytis more accurately as focusing exclusively on Biophytis' fundamentals will not take into account other important factors: Biophytis Total Value Analysis
Biophytis is currently anticipated to have valuation of 9.73 B with market capitalization of 2.61 M, debt of 8.27 M, and cash on hands of 23.93 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biophytis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.73 B | 2.61 M | 8.27 M | 23.93 M |
Biophytis Asset Utilization
One of the ways to look at asset utilization of Biophytis is to check how much profit was generated for every dollar of assets it reports. Biophytis shows a negative utilization of assets of -0.53 percent, losing $0.005278 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biophytis shows how discouraging it operates for each dollar spent on its assets.Biophytis Ownership Allocation
Almost 99.96 percent of Biophytis outstanding shares are held by general public with 0.04 % by other corporate entities.Biophytis Profitability Analysis
Net Loss for the year was (17.03 M) with profit before overhead, payroll, taxes, and interest of 0.About Biophytis Valuation
The delisted stock valuation mechanism determines Biophytis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biophytis based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biophytis. We calculate exposure to Biophytis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biophytis's related companies.Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. Biophytis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Biophytis Growth Indicators
Investing in growth stocks can be very risky. If the company such as Biophytis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |